APPLIED DNA SCIENCES INC (APDN)
US03815U3005 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.36M | 7.15M | 15.22M | 6.55M | 7.79M | |||
| Receivables | 450.76K | 255.50K | 3.07M | 2.80M | 190.00K | |||
| Inventories | 377.29K | 330.03K | 600.00K | 1.37M | 500.00K | |||
| Other Current Assets | 402.95K | 389.24K | 1.06M | 570.00K | 600.00K | |||
| Total Current Assets | 4.59M | 8.13M | 19.94M | 11.30M | 9.08M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.66M | 2.08M | 2.22M | 3.02M | 1.28M | |||
| Goodwill | N/A | N/A | N/A | 0.00 | 290.00K | |||
| Intangibles | 2.70M | 2.70M | N/A | 0.00 | 610.00K | |||
| Other Non-Current Assets | 967.55K | 750.00K | 100.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 5.32M | 5.53M | 2.33M | 3.12M | 2.26M | |||
| TOTAL ASSETS | 9.91M | 13.65M | 22.27M | 14.42M | 11.34M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 1.83M | |||
| Accrued Expenses | 1.52M | 1.70M | 1.88M | 980.00K | 680.00K | |||
| Accounts Payable | 1.02M | 1.07M | 1.74M | 2.01M | 1.25M | |||
| Other Current Liabilities | 54.04K | 76.44K | 560.00K | 280.00K | 510.00K | |||
| Total Current Liabilities | 2.59M | 2.85M | 4.19M | 3.27M | 4.27M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 520.00K | |||
| Deferred Taxes/Income | 684.12K | 684.12K | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 2.51M | 5.25M | 5.17M | 30.00K | 850.00K | |||
| Total Non-Current Liabilities | 3.09M | 5.86M | 5.16M | 30.00K | 1.35M | |||
| TOTAL LIABILITIES | 5.68M | 8.70M | 9.35M | 3.30M | 5.62M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -303.63M | -302.45M | -292.50M | -284.12M | -269.84M | |||
| Additional Paid In Capital | 307.85M | 307.38M | 305.40M | 295.23M | 275.55M | |||
| Minority Interest | -78.75K | -2.89K | 0.00 | -10.00K | -10.00K | |||
| Common Shares | 13.72K | 13.66K | 10.00K | 10.00K | 10.00K | |||
| Shares Outstanding | 13.66M | 13.66M | 12.91M | 7.49M | 5.14M | |||
| Tangible Book Value per Share | 0.11 | 0.16 | 1.00 | 1.48 | 0.94 | |||
| Total Shareholders' Equity | 4.23M | 4.95M | 12.91M | 11.11M | 5.72M | |||
| TOTAL LIABILITIES AND EQUITY | 9.91M | 13.65M | 22.27M | 14.42M | 11.34M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.09 | |||
| Current Ratio | 1.77 | 2.86 | 4.76 | 3.46 | 2.13 | |||
| Return On Assets (ROA) | -73.49% | -72.86% | -37.63% | -99.10% | -114.90% | |||
| Return On Equity (ROE) | -172.13% | -200.90% | -64.91% | -128.62% | -227.80% | |||
All data in USD